The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
The importance of efflux pumps in bacterial antibiotic resistance
Open accessAbstract
Efflux pumps are transport proteins involved in the extrusion of toxic substrates (including virtually all classes of clinically relevant antibiotics) from within cells into the external environment. These proteins are found in both Gram-positive and -negative bacteria as well as in eukaryotic organisms.1 Pumps may be specific for one substrate or may transport a range of structurally dissimilar compounds (including antibiotics of multiple classes); such pumps can be associated with multiple drug resistance (MDR). In the prokaryotic kingdom there are five major families of efflux transporter:2 MF (major facilitator), MATE (multidrug and toxic efflux), RND (resistance-nodulation-division), SMR (small multidrug resistance) and ABC (ATP binding cassette). All these systems utilize the proton motive force as an energy source,3 apart from the ABC family, which utilizes ATP hydrolysis to drive the export of substrates. Recent advances in DNA technology and the advent of the genomic era have led to the identification of numerous new members of the above families, and the ubiquitous nature of efflux pumps is remarkable. Transporters that efflux multiple substrates, including antibiotics, have not evolved in response to the stresses of the antibiotic era. All bacterial genomes studied contain several different efflux pumps; this indicates their ancestral origins. It has been estimated that ∼5–10% of all bacterial genes are involved in transport and a large proportion of these encode efflux pumps.2,4 There is some debate as to the ‘normal’ physiological role of efflux transporters, as antibiotic susceptible as well as resistant bacteria carry and express these genes. In many cases, efflux pump genes are part of an operon, with a regulatory gene controlling expression. Increased expression is associated with resistance to the substrates, e.g. resistance to bile salts and some antibiotics in Escherichia coli is mediated by over-expression of acrAB.5 Although genes encoding efflux pumps can be found on plasmids, the carriage of efflux pump genes on the chromosome gives the bacterium an intrinsic mechanism that allows survival in a hostile environment (e.g. the presence of antibiotics), and so mutant bacteria that over-express efflux pump genes can be selected without the acquisition of new genetic material. It is probable that these pumps arose so that noxious substances could be transported out of the bacterium, allowing survival. Indeed it is now widely accepted that the ‘intrinsic resistance’ of Gram-negative bacteria to certain antibiotics relative to Gram-positive bacteria is a result of the activity of efflux systems.6 Efflux systems that contribute to antibiotic resistance have been described from a number of clinically important bacteria, including Campylobacter jejuni (CmeABC7,8), E. coli (AcrAB-TolC, AcrEF-TolC, EmrB, EmrD9), Pseudomonas aeruginosa (MexAB-OprM, MexCD-OprJ, MexEF-OprN and MexXY-OprM9), Streptococcus pneumoniae (PmrA10), Salmonella typhimurium (AcrB11) and Staphylococcus aureus (NorA12). All of these systems efflux fluoroquinolones and the RND pumps (CmeB, AcrB and the Mex pumps) also export multiple antibiotics. Over-expression of efflux pumps can result from mutations within local repressor genes13–15 or may result from activation of a regulon regulated by a global transcriptional regulator such as MarA or SoxS of E. coli.16,17 The broad substrate range of efflux systems is of concern, as often over-expression of a pump will result in resistance to antibiotics of more than one class as well as some dyes, detergents and disinfectants (including some commonly used biocides). Cross-resistance is also a problem; exposure to any one agent that belongs to the substrate profile of a pump would favour over-expression of that pump and consequent cross-resistance to all other substrates of the pump. These may include clinically relevant antibiotics. An example of this is seen again with the mexAB system of P. aeruginosa; mutants that over-produce MexAB are less susceptible, if not fully resistant to a range of antibiotics (fluoroquinolones, β-lactams, chloramphenicol and trimethoprim) but also triclosan, a commonly used household biocide.18 The potential misuse of biocides and possible selection of bacteria cross-resistant to antibiotics has recently been debated in this journal and elsewhere.19–22 Over-expression of a multidrug resistance efflux pump alone often does not confer high-level, clinically significant resistance to antibiotics. However, such bacteria are better equipped to survive antibiotic pressure and develop further mutations in genes encoding the target sites of antibiotics.23 It has been shown that fluoroquinolone-resistant strains of E. coli are selected 1000-fold more readily from mar mutants than wild-type bacteria,24 and highly fluoroquinolone-resistant E. coli contain mutations in genes encoding the target topoisomerase enzymes and have reduced accumulation and increased efflux (p
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Proton-dependent multidrug efflux systems
Paulsen, I. T., Brown, M. H., & Skurray, R. A. (1996) · Microbiological Reviews · doi:10.1128/mmbr.60.4.575-608.1996 · Cited by 1,198
Lomovskaya, O., Warren, M. S., Lee, A., Galazzo, J., Fronko, R., Lee, M., Blais, J., Cho, D., Chamberland, S., Renau, T., et al. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.1.105-116.2001 · Cited by 903
CmeABC Functions as a Multidrug Efflux System in Campylobacter jejuni
Lin, J., Michel, L. O., & Zhang, Q. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.7.2124-2131.2002 · Cited by 528
Active efflux of bile salts by Escherichia coli
Thanassi, D. G., Cheng, L. W., & Nikaido, H. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.8.2512-2518.1997 · Cited by 471
Regulation of chromosomally mediated multiple antibiotic resistance: the mar regulon
Alekshun, M. N., & Levy, S. B. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.10.2067 · Cited by 470
Chuanchuen, R., Beinlich, K., Hoang, T. T., Becher, A., Karkhoff-Schweizer, R. R., & Schweizer, H. P. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.2.428-432.2001 · Cited by 426
Van Bambeke, F., Balzi, E., & Tulkens, P. M. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00291-4 · Cited by 404
Li, X. Z., Livermore, D. M., & Nikaido, H. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.8.1732 · Cited by 402
Ma, D., Alberti, M., Lynch, C., Nikaido, H., & Hearst, J. E. (1996) · Molecular Microbiology · doi:10.1046/j.1365-2958.1996.357881.x · Cited by 390
Cohen, S. P., McMurry, L. M., Hooper, D. C., Wolfson, J. S., & Levy, S. B. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.8.1318 · Cited by 376
Cited by
Multidrug-resistance efflux pumps ? not just for resistance
Piddock, L. J. V. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1464 · Cited by 1,522
Molecular mechanisms of antibiotic resistance revisited
Darby, E. M., Trampari, E., Siasat, P., Gaya, M. S., Alav, I., Webber, M. A., & Blair, J. M. A. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00820-y · Cited by 1,398
Self-citationClinically Relevant Chromosomally Encoded Multidrug Resistance Efflux Pumps in Bacteria
Piddock, L. J. V. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.19.2.382-402.2006 · Cited by 1,231
An omics-based framework for assessing the health risk of antimicrobial resistance genes
Zhang, A.-N., Gaston, J. M., Dai, C. L., Zhao, S., Poyet, M., Groussin, M., Yin, X., Li, L.-G., van Loosdrecht, M. C. M., Topp, E., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25096-3 · Cited by 939
Review on plant antimicrobials: a mechanistic viewpoint
Khameneh, B., Iranshahy, M., Soheili, V., & Fazly Bazzaz, B. S. (2019) · Antimicrobial Resistance & Infection Control · doi:10.1186/s13756-019-0559-6 · Cited by 891
Review article: the global emergence of Helicobacter pylori antibiotic resistance
Thung, I., Aramin, H., Vavinskaya, V., Gupta, S., Park, J. Y., Crowe, S. E., & Valasek, M. A. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13497 · Cited by 743
Intrinsic antibiotic resistance: Mechanisms, origins, challenges and solutions
Cox, G., & Wright, G. D. (2013) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2013.02.009 · Cited by 697
Efflux-mediated multiresistance in Gram-negative bacteria
Poole, K. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.00763.x · Cited by 613
The antibacterial properties of phenolic isomers, carvacrol and thymol
Kachur, K., & Suntres, Z. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2019.1675585 · Cited by 558
Role of bacterial efflux pumps in biofilm formation
Alav, I., Sutton, J. M., & Rahman, K. M. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky042 · Cited by 504
High-throughput sequencing provides insights into genome variation and evolution in Salmonella Typhi
Holt, K. E., Parkhill, J., Mazzoni, C. J., Roumagnac, P., Weill, F.-X., Goodhead, I., Rance, R., Baker, S., Maskell, D. J., Wain, J., et al. (2008) · Nature Genetics · doi:10.1038/ng.195 · Cited by 497
Multidrug efflux pumps in Gram-negative bacteria and their role in antibiotic resistance.
Blair, J. M., Richmond, G. E., & Piddock, L. J. (2014) · Future Microbiology · doi:10.2217/fmb.14.66 · Cited by 481
Mathew, A. G., Cissell, R., & Liamthong, S. (2007) · Foodborne Pathogens and Disease · doi:10.1089/fpd.2006.0066 · Cited by 462
Efflux pump inhibitors for bacterial pathogens: From bench to bedside
Sharma, A., Gupta, V. K., & Pathania, R. (2019) · Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_2079_17 · Cited by 458
Simões, M., Bennett, R. N., & Rosa, E. A. S. (2009) · Natural Product Reports · doi:10.1039/b821648g · Cited by 444
Metal Resistance and Its Association With Antibiotic Resistance
Pal, C., Asiani, K., Arya, S., Rensing, C., Stekel, D. J., Larsson, D. G. J., & Hobman, J. L. (2017) · Advances in Microbial Physiology · doi:10.1016/bs.ampbs.2017.02.001 · Cited by 438
The emergence of antibiotic resistance by mutation
Woodford, N., & Ellington, M. J. (2007) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01492.x · Cited by 417
“Resistance mediated by these mutations is enhanced by other mutations affecting the expression of efflux pumps [11–16].”
BackgroundRoberts, M. C. (2008) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2008.01145.x · Cited by 392
Moore, J. E., Corcoran, D., Dooley, J. S. G., Fanning, S., Lucey, B., Matsuda, M., McDowell, D. A., M�graud, F., Cherie Millar, B., O?Mahony, R., et al. (2005) · Veterinary Research · doi:10.1051/vetres:2005012 · Cited by 390
Bacterial defences: mechanisms, evolution and antimicrobial resistance
Smith, W. P. J., Wucher, B. R., Nadell, C. D., & Foster, K. R. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-023-00877-3 · Cited by 385
Enhanced Efflux Activity Facilitates Drug Tolerance in Dormant Bacterial Cells
Pu, Y., Zhao, Z., Li, Y., Zou, J., Ma, Q., Zhao, Y., Ke, Y., Zhu, Y., Chen, H., Baker, M. A. B., et al. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.03.035 · Cited by 381
Zhao, R., Yu, K., Zhang, J., Zhang, G., Huang, J., Ma, L., Deng, C., Li, X., & Li, B. (2020) · Water Research · doi:10.1016/j.watres.2020.116318 · Cited by 375
Tannins as an alternative to antibiotics
Farha, A. K., Yang, Q.-Q., Kim, G., Li, H.-B., Zhu, F., Liu, H.-Y., Gan, R.-Y., & Corke, H. (2020) · Food Bioscience · doi:10.1016/j.fbio.2020.100751 · Cited by 375
Gaurav, A., Bakht, P., Saini, M., Pandey, S., & Pathania, R. (2023) · Microbiology · doi:10.1099/mic.0.001333 · Cited by 351
Breakthroughs in bacterial resistance mechanisms and the potential ways to combat them
Khameneh, B., Diab, R., Ghazvini, K., & Fazly Bazzaz, B. S. (2016) · Microbial Pathogenesis · doi:10.1016/j.micpath.2016.02.009 · Cited by 345
Antimicrobial Metal Nanomaterials: From Passive to Stimuli‐Activated Applications
Cheeseman, S., Christofferson, A. J., Kariuki, R., Cozzolino, D., Daeneke, T., Crawford, R. J., Truong, V. K., Chapman, J., & Elbourne, A. (2020) · Advanced Science · doi:10.1002/advs.201902913 · Cited by 337
High-Specificity Targeted Functional Profiling in Microbial Communities with ShortBRED
Kaminski, J., Gibson, M. K., Franzosa, E. A., Segata, N., Dantas, G., & Huttenhower, C. (2015) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1004557 · Cited by 333
Bacterial exo-polysaccharides in biofilms: role in antimicrobial resistance and treatments
Singh, S., Datta, S., Narayanan, K. B., & Rajnish, K. N. (2021) · Journal of Genetic Engineering and Biotechnology · doi:10.1186/s43141-021-00242-y · Cited by 331
Role of mycobacterial efflux transporters in drug resistance: an unresolved question
Rossi, E. D., Aínsa, J. A., & Riccardi, G. (2006) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2005.00002.x · Cited by 328
Borges, A., Abreu, A., Dias, C., Saavedra, M., Borges, F., & Simões, M. (2016) · Molecules · doi:10.3390/molecules21070877 · Cited by 308
Mechanisms of action of newer antibiotics for Gram-positive pathogens
Hancock, R. E. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70051-7 · Cited by 295
Lamers, R. P., Cavallari, J. F., & Burrows, L. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060666 · Cited by 291
Helicobacter pylori treatment: antibiotics or probiotics
Goderska, K., Agudo Pena, S., & Alarcon, T. (2018) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-017-8535-7 · Cited by 288
Antibiotic Adjuvants: Make Antibiotics Great Again!
Douafer, H., Andrieu, V., Phanstiel, O., & Brunel, J. M. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01781 · Cited by 272
The Concept of an Ideal Antibiotic: Implications for Drug Design
Gajdács, M. (2019) · Molecules · doi:10.3390/molecules24050892 · Cited by 271
Bacterial efflux systems and efflux pumps inhibitors
Marquez, B. (2005) · Biochimie · doi:10.1016/j.biochi.2005.04.012 · Cited by 270
The Potential of Human Peptide LL-37 as an Antimicrobial and Anti-Biofilm Agent
Ridyard, K. E., & Overhage, J. (2021) · Antibiotics · doi:10.3390/antibiotics10060650 · Cited by 270
Minimising antibiotic resistance
Livermore, D. M. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70166-3 · Cited by 268
Annunziato, G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20235844 · Cited by 256
Heavy Metal Induced Antibiotic Resistance in Bacterium LSJC7
Chen, S., Li, X., Sun, G., Zhang, Y., Su, J., & Ye, J. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161023390 · Cited by 128
Carballo-Pacheco, M., Nicholson, M. D., Lilja, E. E., Allen, R. J., & Waclaw, B. (2020) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1007930 · Cited by 18
Nair, V. G., Unnikrishnan, V. K., Muralidharan, N., Venkatathri, B. N. S., Lowrence, R. C., YBRD, R., Narbhavi, D., A, A., N, P., & Nagarajan, S. (2025) · Scientific Reports · doi:10.1038/s41598-025-17404-4 · Cited by 8
Metadata
- Authors
- Webber, M. A.
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-12-12
- Volume
- 51
- Issue
- 1
- Pages
- 9-11
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2129026291
- Cited by
- 853
- References
- 31
- FWCI
- 4.17
- Type
- journal article
- Language
- fr
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.